Central Neuropathic Mechanisms in Pain Signaling Pathways: Current Evidence and Recommendations

Omar Viswanath,Ivan Urits,James Burns,Karina Charipova,Kyle Gress,Alexandra McNally,Richard D. Urman,Ali Welschmeyer,Amnon A. Berger,Hisham Kassem,Manuel G. Sanchez,Alan D. Kaye,Treniece N. Eubanks,Elyse M. Cornett,Anh L. Ngo
DOI: https://doi.org/10.1007/s12325-020-01334-w
2020-04-10
Advances in Therapy
Abstract:This is a comprehensive review of the current literature on central neuropathic pain mechanisms that is secondary to spinal cord injury. It reviews recent and seminal findings on the pathophysiology, diagnosis, and treatment and compares treatment options and recommendations.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?
The problems that this paper attempts to solve are the pathogenesis, diagnosis, and treatment of central neuropathic pain (CNP) after spinal cord injury (SCI). Specifically: 1. **Pathogenesis**: The paper thoroughly explores multiple pathophysiological mechanisms that lead to CNP after SCI, including the increase of inflammatory mediators, ion - channel dysfunction, and neuron - glial cell interactions. These mechanisms work together to cause sensitization of sensory nerves, thereby triggering pain. 2. **Diagnosis**: Since the diagnosis of CNP is rather complex and difficult to determine, the paper discusses the current standards and tools used for diagnosing CNP, such as the AAPT diagnostic criteria and the criteria of the International Association for the Study of Pain (IASP). Meanwhile, it also mentions the application of imaging, neurophysiological or biological tests in confirming CNP. 3. **Treatment**: The paper reviews the current methods for treating CNP, pointing out that the efficacy of traditional treatment methods such as gabapentinoids, tricyclic antidepressants (TCAs), and selective serotonin - norepinephrine reuptake inhibitors (SNRIs) is limited. In addition, it also introduces the potential efficacy of several new treatment methods, such as baclofen and ziconotide, as well as non - drug intervention methods, such as brain sensitization and biofeedback techniques. In conclusion, this paper aims to comprehensively review and evaluate the current research progress on CNP after SCI, in order to provide guidance for future clinical practice and research.